Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 30.60
  • 52 Week Low: 6.50
  • Currency: UK Pounds
  • Shares Issued: 687.01m
  • Volume: 0

Latest ShareCast News

hVIVO secures largest standalone lab contract to date

By Josh White

Date: Tuesday 21 Jan 2025

(Sharecast News) - hVIVO announced on Tuesday that it has secured its largest standalone laboratory contract to date, with its hLAB division signing a £2.7m deal with a US-based biotechnology client, bringing the total value of the project to £3.2m.

hVIVO manufactures human challenge agent for Omicron

By Josh White

Date: Thursday 16 Mar 2023

(Sharecast News) - Specialist contract research organisation hVIVO has successfully manufactured its Omicron human challenge agent, it announced on Thursday.

Open Orphan signs £10.4m contract with global pharma client

By Josh White

Date: Monday 22 Aug 2022

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a £10.4m contract with an existing, unnamed top-five global pharmaceutical client to manufacture a new batch of H1N1 flu challenge virus, and to conduct a human challenge trial to test the client's antiviral product.

Open Orphan wins £7.2m contract for RSV human st... 14-Jun-2022 ShareCast
Open Orphan wins £7.3m human flu study contract 18-May-2022 ShareCast
Open Orphan wins £5m contract for human study in... 25-Mar-2022 ShareCast
Open Orphan appoints Mo Khan as its new chief ex... 24-Feb-2022 ShareCast
Open Orphan launches project collecting viral st... 14-Feb-2022 ShareCast
Open Orphan reports on world's first Covid-19 ch... 02-Feb-2022 ShareCast
Open Orphan signs £5m human flu study contract 21-Dec-2021 ShareCast
Open Orphan signs contract to test antiviral can... 10-Dec-2021 ShareCast
Open Orphan subsidiary locks in £5.1m contract w... 17-Nov-2021 ShareCast
Open Orphan subsidiary secures contract renewal ... 15-Nov-2021 ShareCast
Open Orphan signs £5.7m contract with biotech sp... 20-Sep-2021 ShareCast
Open Orphan secures €900,000 contract with... 14-Jul-2021 ShareCast
Open Orphan subsidiary scores 'significant contr... 09-Jul-2021 ShareCast
Cathal Friel-led Poolbeg Pharma set to float on ... 17-Jun-2021 ShareCast
Open Orphan subsidiary signs contract to make Co... 10-May-2021 ShareCast
Open Orphan makes progress with Covid-19 charact... 25-Mar-2021 ShareCast
Open Orphan subsidiary awarded contract with Oxf... 09-Mar-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 16.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 30.60
52 Week Low 6.50
Volume 0
Shares Issued 687.01m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
75.69% below the market average75.69% below the market average75.69% below the market average75.69% below the market average75.69% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Price Trend
56.13% below the market average56.13% below the market average56.13% below the market average56.13% below the market average56.13% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average
Income
80.3% below the market average80.3% below the market average80.3% below the market average80.3% below the market average80.3% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
65.05% above the market average65.05% above the market average65.05% above the market average65.05% above the market average65.05% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 3
Buy 4
Neutral 0
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 18-Apr-24
Paid 11-Jun-25 20-May-24
Amount 0.20p 0.20p

Trades for 30-May-2025

Time Volume / Share Price
12:55 192,900 @ 8.81p
12:54 11,305 @ 8.81p
12:53 6,500 @ 8.73p
12:52 11,279 @ 8.80p
12:50 22,694 @ 8.80p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page